Effects of Saccharomyces Boulardii CNCM I-745 on Antibiotic-Associated Perturbation in Children Treated for Acute Respiratory Infections (RESTORE Study) (RESTORE)
Effect of Saccharomyces Boulardii CNCM I-745 on Antibiotic-perturbed Microbiota in Children: RESTORE STUDY
Sponsor: Eskisehir Osmangazi University
Listed as NCT07015736, this PHASE4 trial focuses on ACUTE SINUSITIS and Acute Otitis Media and remains ongoing. Sponsored by Eskisehir Osmangazi University, it has been updated 3 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting PHASE4
Status: Not Yet Recruiting → Active Not Recruiting
-
Sep 2025 — Feb 2026 [monthly]
Not Yet Recruiting PHASE4
-
Jul 2025 — Sep 2025 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Eskisehir Osmangazi University
For direct contact, visit the study record on ClinicalTrials.gov .